L. Carroccia et al. / Tetrahedron 67 (2011) 5375e5381
5381
3
ꢂ70.4 (d, JFeH¼3.4 Hz, 3F, major); HRMS: m/z [MþNa]þ calcd for
References and notes
C8H14F3NNaO: 220.0925; found: 220.0931.
1. (a) Guest Curr. Org. Chem.; Liu, Z.-P., Ed.; 2010; Vol. 14, pp 888e999; (b) Guest
Curr. Org. Synth.; Lopez, S. E., Ed.; 2010; Vol. 7, pp 402e531; (c) Verniest, G.; Piron,
K.; Van Hende, E.; Thuring, J. W.; Macdonald, G.; Deroose, F.; De Kimpe, N. Org.
Biomol. Chem. 2010, 8, 2509e2512; (d) Kawai, H.; Kusuda, A.; Nakamura, S.; Shiro,
M.; Shibata, N. Angew. Chem., Int. Ed. 2009, 48, 6324e6327; (e) Lemal, D. M.;
Ramanathan, S. In Fluorinated Heterocyclic Compounds: Synthesis, Chemistry, and
Applications; Petrov, V. A., Ed.; John Wiley: Hoboken, 2009; (f) O’Hagan, D. Chem.
4.9.4. 2-(1,3-Dimethylbutyl)-3-(trifluoromethyl)oxaziridine
(5h). Orange oil; 0.16 g; IR: 1416 cmꢂ1; 1H NMR (300 MHz, CDCl3):
d
¼0.86e0.95(m, 12H), 1.15 (d, 3J¼6.6 Hz, 3H, minor), 1.26 (d,
3J¼6.2 Hz, 3H, major), 1.34e1.45 (m, 2H), 1.61e1.87 (m, 4H),
3
2.19e2.30 (m, 2H), 4.17 (q, JHeF¼3.3 Hz, 1H, minor), 4.22 (q,
ꢁ
ꢁ
Soc. Rev. 2008, 37, 308e319; (g) Begue, J.-P.; Bonnet-Delpon, D. In Bioorganic and
Medicinal Chemistry of Fluorine; J. Wiley: Hoboken, NJ, 2008; (h) Kirsch, P. In
Modern Fluoroorganic Chemistry; Wiley-VCH: Weinheim, 2004; (i) Chambers, R.
D. Fluorine in Organic Chemistry; Oxford: , Blackwell, 2004.
3JHeF¼3.2 Hz, 1H, major); 13C NMR (75 MHz, CDCl3):
¼16.6 (mi-
d
nor), 19.2 (major), 22.3, 26.6 (2C), 23.0, 24.5 (2C), 42.2 (minor), 44.9
2
(major), 64.4 (minor), 64.6 (major), 74.0 (q, JCeF¼42.1 Hz, CeCF3,
ꢁ
ꢁ
2. (a) Begue, J. P.; Bonnet-Delpon, D.; Crousse, B.; Legros, J. Chem. Soc. Rev. 2005, 34,
562e572; (b) Qiu, X.-L.; Meng, W.-D.; Qing, F.-L. Tetrahedron 2004, 60,
6711e6745; (c) Biomedical Frontiers of Fluorine Chemistry; Ojima, I., McCarthy, J.
R., Welch, J. T., Eds.; ACS Books, American Chemical Society: Washington, DC,
1996; (d) Fluorine-containing Amino Acids: Synthesis and Properties; Kukhar, V. P.,
Soloshonok, V. A., Eds.; John Wiley: Chichester, UK, 1995.
2
minor), 75.4 (q, JCeF¼41.8 Hz, CeCF3, major), 120.8 (q,
1JCeF¼277.7 Hz, CF3, minor), 120.9 (q, 1JCeF¼277.5 Hz, CF3, major);
19F NMR (282.2 MHz, CDCl3):
d
¼ꢂ72.9 (d, 3JFeH¼3.4 Hz, 3F, minor),
ꢂ70.5 (d, JFeH¼3.4 Hz, 3F, major); HRMS: m/z [MþNa]þ calcd for
3
3. (a) Mikami, K.; Itoh, Y.; Yamanaka, M. Chem. Rev. 2004, 104, 1e16; (b) Ram-
achandran, P. V., Ed. Asymmetric Fluoroorganic Chemistry. Synthesis, Applications,
and Future Directions; ACS Symposium Series 746; American Chemical Society:
Washington, DC, 2000. (c) Soloshonok, V. A. Enantiocontrolled Synthesis of
Fluoro-organic Compounds; Wiley: Chichester, UK, 1999; (d) Iseki, K. Tetrahedron
1998, 54, 13887e13914; (e) Resnati, G. Tetrahedron 1993, 49, 9385e9445; (f)
Bravo, P.; Resnati, G. Tetrahedron: Asymmetry 1990, 1, 661e692.
4. (a) Fioravanti, S.; Pellacani, L.; Ramadori, F.; Tardella, P. A. Tetrahedron Lett. 2007,
48, 7821e7824; (b) Fioravanti, S.; Colantoni, D.; Pellacani, L.; Tardella, P. A.
J. Org. Chem. 2005, 70, 3296e3298; (c) Colantoni, D.; Fioravanti, S.; Pellacani, L.;
Tardella, P. A. Org. Lett. 2004, 6, 197e200.
5. (a) Fioravanti, S.; Morreale, A.; Pellacani, L.; Tardella, P. A. Eur. J. Org. Chem.
2003, 4549e4552; (b) Fioravanti, S.; Morreale, A.; Pellacani, L.; Tardella, P. A.
Synthesis 2001, 1975e1978; (c) Fioravanti, S.; Morreale, A.; Pellacani, L.; Tar-
della, P. A. Tetrahedron Lett. 2001, 42, 1171e1173.
6. Carroccia, L.; Fioravanti, S.; Pellacani, L.; Tardella, P. A. Synthesis 2010,
4096e4100.
7. The same imine might behave like a base; therefore in these reaction condi-
tions yields up to 50% can be obtained: Fioravanti, S.; Olivieri, L.; Pellacani, L.;
Tardella, P. A. Tetrahedron Lett. 1998, 39, 6391e6392 A third hypothesis, put
forward by a referee, could be the direct addition of nosyloxycarbamate across
the imine bond.
8. (a) Fioravanti,S.;Marchetti,F.;Morreale,A.;Pellacani,L.;Tardella,P.A.Org.Lett.2003,
5,1019e1021; (b) Hanessian, S.; Johnstone, S. J. Org. Chem.1999, 64, 5896e5903.
9. De Vitis, L.; Florio, S.; Granito, C.; Ronzini, L.; Capriati, V.; Luisi, R.; Pilati, T.
Tetrahedron 2004, 60, 1175e1182.
C8H14F3NNaO: 220.0925; found: 220.0935.
4.9.5. Ethyl (2S,3S)-3-(trifluoromethyl)-2-[(R)-1,2,2-trimethylpropyl]
25
oxaziridine [(R,S,S)-5g]. Yellow oil; 0.13 g; [
a
]
D
ꢂ22.0 (c 1.2,
CHCl3); IR: 1419 cmꢂ1
;
1H NMR (300 MHz, CDCl3):
d
¼1.0 (s, 9H),
1.21 (d, 3J¼6.4 Hz, 3H), 1.94 (q, 3J¼6.4 Hz, 1H), 4.31 (q, 3JHeF¼3.3 Hz,
1H); 13C NMR (75 MHz, CDCl3):
d
¼14.7, 26.6 (3C), 34.7, 74.3, 77.5 (q,
2JCeF¼41.1 Hz, CeCF3), 120.9 (q, JCeF¼277.5 Hz, CF3); 19F NMR
1
3
(282.2 MHz, CDCl3):
d
¼ꢂ70.4 (d, JFeH¼3.4 Hz, 3F); HRMS: m/z
[MþNa]þ calcd for C8H14F3NNaO: 220.0925; found: 220.0931.
4.9.6. Ethyl (2R,3R)-3-(trifluoromethyl)-2-[(1R)-1,2,2-
trimethylpropyl]oxaziridine [(R,R,R)-5g]. Colorless oil; 0.03 g;
25
[
a]
þ18.4 (c 1.4, CHCl3); IR: 1421 cmꢂ1
;
1H NMR (300 MHz,
D
CDCl3):
d
¼0.99 (s, 9H), 1.07 (d, 3J¼6.9 Hz, 3H), 1.90 (q, 3J¼6.9 Hz,
1H), 4.09 (q, 3JHeF¼3.3 Hz, 1H); 13C NMR (75 MHz, CDCl3):
d¼12.0,
2
26.4 (3C), 36.1, 73.2 (q, JCeF¼42.1 Hz, CeCF3), 74.2, 121.1 (q,
1JCeF¼277.6 Hz, CF3); 19F NMR (282.2 MHz, CDCl3):
¼ꢂ71.2 (d,
d
3JFeH¼3.4 Hz, 3F); HRMS: m/z [MþNa]þ calcd for C8H14F3NNaO:
220.0925; found: 220.0929.
10. The equilibrium geometries of the two diastereomers were obtained from
B3PW91/6-311þþG** optimizations. Single-point energy calculations of
B3PW91/aug-cc-pvtz //B3PW91/6-311þþG** were accomplished to determine
a better evaluation of relative stability. Further, zero-point energy and thermal
corrections at 298 K were included to improve the energy difference value.
Quantum mechanical calculations were performed using the GAUSSIAN 03,
revision C.02 package Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.;
Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A., Jr.; Vreven, T.; Kudin, K. N.;
Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.;
Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara,
M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.;
Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.;
Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.;
Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.;
Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.;
Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Ragha-
vachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cio-
slowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.;
Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.;
Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez,
C.; Pople, J. A. Gaussian 03, Revision C.02; Gaussian: Wallingford CT, 2004.
11. Davis, F. A.; Chen, B.-C. Chem. Rev. 1992, 92, 919e934.
4.9.7. Ethyl (2R* ,3R* )-3-(trifluoromethyl)-2-[(S)-1,2,2-
trimethylpropyl]oxaziridine [(S,R*,R*)-5g]. Orange oil; 0.17 g; IR:
1422 cmꢂ1; 1H NMR (300 MHz, CDCl3):
d
¼0.99 (s, 9H, minor), 1.00
(s, 9H, major), 1.07 (d, 3J¼6.9 Hz, 3H, minor), 1.21 (d, 3J¼6.4 Hz, 3H,
major), 1.87e1.98 (m, 2H), 4.09 (q, 3JHeF¼3.3 Hz, 1H, minor), 4.31 (q,
3JHeF¼3.3 Hz,1H, major); 13C NMR (75 MHz, CDCl3):
¼11.9 (minor),
d
14.7 (major), 26.3 (3C, minor), 26.6 (3C, major), 34.8 (major), 36.1
2
(minor), 73.2 (q, JCeF¼42.1 Hz, CeCF3, minor), 74.2 (2C), 77.5 (q,
2JCeF¼41.1 Hz, CeCF3, major), 120.9 (q, 1JCeF¼277.5 Hz, CF3, major),
121.2 (q, 1JCeF¼277.5 Hz, CF3, minor); 19F NMR (282.2 MHz, CDCl3):
3
3
d
¼ꢂ71.2 (d, JFeH¼3.4 Hz, 3F, minor), ꢂ70.4 (d, JFeH¼3.4 Hz, 3F,
major); HRMS: m/z [MþNa]þ calcd for C8H14F3NNaO: 220.0925;
found: 220.0931.
Acknowledgements
12. Mishra, J. K. Synlett 2005, 543e544 and refs therein.
ꢀ
Italian MIUR; and Universita degli Studi di Roma ‘La Sapienza’
13. (a) Petrov, V. A.; Resnati, G. Chem. Rev. 1996, 96, 1809e1824; (b) DesMarteau, D. D.;
Petrov,V.A.;Montanari,V.;Pregnolato,M.;Resnati,G.J.Org.Chem.1994,59,2762e2765.
14. Blanc, S.; Bordogna, C. A. C.; Buckley, B. R.; Elsegood, M. R. J.; Page, P. C. B. Eur. J.
Org. Chem. 2010, 882e889.
are gratefully acknowledged for financial support (PRIN
2007FJC4SF_005). We thank Dr. Davide Massari for experimental
support.
15. The epoxidation of chlorinated and brominated aldimines in similar conditions
have been reported: De Kimpe, N.; De Corte, B. Tetrahedron 1992, 48, 7345e7362.
16. (a) Page, P. C. B.; Buckley, B. R. N-tert-Butoxycarbonyl(4-cyanophenyl)oxaziridine
In e-EROS, Electronic Encyclopedia of Reagents for Organic Synthesis; John Wiley:
New York, NY, 2005; (b) Metrangolo, P.; Novo, B.; Resnati, G. Oxaziridine, 3-
fluoro-3-(heptafluoropropyl)-2-(nonafluorobutyl)- In e-EROS, Electronic Ency-
clopedia of Reagents for Organic Synthesis; John Wiley: New York, NY, 2005; (c)
Beak, P.; Anderson, D. R.; Jarboe, S. G.; Kurtzweil, M. L.; Woods, K. W. Pure Appl.
Chem. 2000, 72, 2259e2264; (d) Aube, J. Chem. Soc. Rev. 1997, 26, 269e278.
17. Lwowski, W.; Maricich, T. J. J. Am. Chem. Soc. 1965, 87, 3630e3637.
18. (a) Banks, M. R.; Cadogan, J. I. G.; Gosney, I.; Hodgson, P. K. G.; Langridge-Smith,
P. R. R.; Millar, J. R. A.; Taylor, A. T. J. Chem. Soc., Chem. Commun. 1995, 885e886;
(b) Banks, M. R.; Cadogan, J. I. G.; Gosney, I.; Hodgson, P. K. G.; Langridge-Smith,
P. R. R.; Rankin, D. W. H. Synth. Met. 1996, 77, 77e80.
Supplementary data
Supplementary data associated with this article [1H and 13C
NMR spectra of (E)-trifluoromethyl imines 1e,g,i,j, and (S)-1g,j, 3;
diaziridines 2aek, 2a0,c0, (R,S,S)- and (R,R,R)-2g, (S,R*,R*)-2g, (R,S,S)-
and (S,R,R)-2j and 4; oxaziridines 5b,feh, (R,S,S)-5g, (S,R,R)-5g, and
(S,R*,R*)-5g] can be found. Supplementary data associated with